glp 1 medications and muscle loss Weight with GLP-1 medicines does not result in a disproportionate loss of mass or function in obese mice humans Can GLP-1 Medications Affect Athletic

Because Retatrutide is a GLP-1-class agonist, the well-established class safety warnings apply as reference context: Thyroid C-cell tumors / MTC (boxed-warning class effect): GLP-1 receptor agonists carry a boxed warning for thyroid C-cell tumors based on rodent data

It adds that animal reproduction studies suggest potential risk while human data is absent, and that this uncertainty is what drives the conservative clinical recommendations that follow

Studies suggest a link between low vitamin B12 levels and increased risk of preterm delivery

00:03:03 Vickie Danaher Jay says hes lost about 15 pounds since starting therapy, and overall hes tolerated it pretty well